Si Bone Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Si-Bone Inc (SIBN)
Si-Bone Inc stock price live, this page displays NASDAQ SIBN stock exchange data. View the SIBN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Si-Bone Inc real time stock price chart below.
What Is the Si-Bone Inc Stock Price Today?
The Si-Bone Inc stock price today is 18.91.
What Is the Stock Symbol for Si-Bone Inc?
The stock symbol for Si-Bone Inc is "SIBN."
What Stock Exchange Does Si-Bone Inc Trade On?
Si-Bone Inc is listed and trades on the NASDAQ stock exchange.
Is Si-Bone Inc a Good Stock to Buy?
Determining whether Si-Bone Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SIBN quote. (ISIN: US8257041090)
What Is the Si-Bone Inc Stock Price Today?
The Si-Bone Inc stock price today is 18.91.
What Is the Stock Symbol for Si-Bone Inc?
The stock symbol for Si-Bone Inc is "SIBN."
What Stock Exchange Does Si-Bone Inc Trade On?
Si-Bone Inc is listed and trades on the NASDAQ stock exchange.
Is Si-Bone Inc a Good Stock to Buy?
Determining whether Si-Bone Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SIBN quote. (ISIN: US8257041090)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.70
19.07
52 wk Range
11.48
21.89
SIBN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.7019.07
52 wk Range
11.4821.89
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SIBN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
25.00
Upside
+32.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings downwards for the upcoming period
- Si Bone Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
- Si Bone Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Si Bone Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Si Bone Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 25.00
(+32.21% Upside)
Si-Bone Inc SWOT Analysis
Surgical Innovation | SI-BONE's iFuse Implant System drives 22.6% YoY growth, establishing the company as a pioneer in minimally invasive sacroiliac joint surgery |
Financial Health | Strong Q1 2025 performance with $47.3M in sales, 25% YoY increase. Healthy 79.25% gross margin and solid cash position, despite current overvaluation |
Growth Trajectory | Analysts project 15-20%+ annual revenue growth. New product launches and FDA Breakthrough Device Designations poised to expand addressable market |
Market Dynamics | Average analyst price target of $28.50. NTAP reimbursement of $3,960 for iFuse TORQ TNT expected in Q4 2025, potentially catalyzing adoption |
Si-Bone Inc Earnings Call Summary for Q2/2026
- SI-BONE posted Q2 2026 adjusted loss of $0.09/share, beating estimates by $0.07; revenue rose 15.2% to $56M, slightly above $55.92M forecast.
- Adjusted EBITDA surged 178% to $2.8M; company raised low end of 2026 revenue guidance to $231M-$233M, implying 15-16% annual growth.
- U.S. procedure volume increased 15% YoY with 9% sequential growth; gross margin held steady at 79.5% while operating expenses rose just 7.7%.
- Shares fell 10.29% after hours to $16.55 despite earnings beat, as investors focused on Q3 seasonality and continued heavy R&D investment spending.
- Company expects third breakthrough device launch by October pending FDA clearance; expanding sales force to nearly 100 territories by year-end.
Last Updated: 2026/08/03, 23:44
Read Full TranscriptEarnings
Latest Release
Aug 03, 2026
EPS / Forecast
-0,09 / -0,16
Revenue / Forecast
56M / 55,92M
Compare SIBN to Peers and Sector
Metrics to compare | SIBN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSIBNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −57.9x | −9.0x | −0.4x | |
PEG Ratio | −1.43 | −0.38 | 0.00 | |
Price/Book | 4.6x | 3.9x | 2.6x | |
Price / LTM Sales | 4.0x | 1.7x | 3.1x | |
Upside (Analyst Target) | 31.9% | 17.8% | 48.4% | |
Fair Value Upside | Unlock | 11.4% | 6.5% | Unlock |
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Si-Bone (SIBN) Stock Price Today?
The Si-Bone stock price today is 18,91 USD.
What Stock Exchange Does Si-Bone Trade On?
Si-Bone is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Si-Bone?
The stock symbol for Si-Bone is "SIBN."
What Is the Si-Bone Market Cap?
As of today, Si-Bone market cap is 847,52M USD.
What Is Si-Bone's Earnings Per Share (TTM)?
The Si-Bone EPS (TTM) is -0,33.
When Is the Next Si-Bone Earnings Date?
Si-Bone will release its next earnings report on Nov 09, 2026.
From a Technical Analysis Perspective, Is SIBN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Si-Bone Stock Split?
Si-Bone has split 0 times.
How Many Employees Does Si-Bone Have?
Si-Bone has 376 employees.
What is the current trading status of Si-Bone (SIBN)?
As of Aug 14, 2026, Si-Bone (SIBN) is trading at a price of 18,91 USD, with a previous close of 18,95 USD. The stock has fluctuated within a day range of 18,70 USD to 19,07 USD, while its 52-week range spans from 11,48 USD to 21,89 USD.
What Is Si-Bone (SIBN) Price Target According to Analysts?
The average 12-month price target for Si-Bone is 25,00 USD, with a high estimate of 32 USD and a low estimate of 20 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +32,21% Upside potential.
What Is the SIBN Premarket Price?
SIBN's last pre-market stock price is 19,06 USD. The pre-market share volume is 140,00, and the stock has decreased by 0,11, or 0,58%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.